Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia

The American Journal of Cardiology
J M MostazaScott M Grundy

Abstract

Pravastatin treatment of combined hyperlipidemia lowers low-density lipoprotein effectively; nicotinic acid lowers remnant cholesterol and raises high-density lipoprotein. A combination of these 2 drugs may be indicated for optimal treatment of lipoprotein abnormalities in combined hyperlipidemia.

References

Jun 1, 1990·Archives of Internal Medicine·G L Vega, S M Grundy
May 1, 1995·The Journal of Clinical Investigation·S ReynisdottirP Arner
Oct 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·G FranceschiniC R Sirtori
Nov 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·G P JarvikE Wijsman

❮ Previous
Next ❯

Citations

Feb 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jonathan C CohenHelen H Hobbs
Jul 11, 2002·The American Journal of Cardiology·Frank M SacksLemuel A Moye
Jul 5, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Christine AhlströmJohan Gabrielsson
Oct 12, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Christine AhlströmJohan Gabrielsson
Oct 24, 1998·Endocrinology and Metabolism Clinics of North America·S M Grundy
Sep 8, 2009·The American Journal of Cardiology·Alice Y ChangBenjamin D Levine
Apr 4, 1998·The American Journal of Cardiology·S M Grundy
Apr 4, 1998·The American Journal of Cardiology·G L Vega, S M Grundy
Jan 18, 2005·Journal of the American College of Cardiology·Rakesh S BirjmohunErik S G Stroes
Apr 3, 2004·Journal of Lipid Research·Marleen M J Van GreevenbroekTjerk W A De Bruin
Apr 9, 2011·Postgraduate Medicine·James M BackesPatrick M Moriarty

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.